Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mesenchymal Stem Cells as Determinants of Tissue Aging
Rochester-Buffalo Neonatal Research Group
Strengthening Key Health Systems and Coordination for HIV/AIDS Prevention, Care,
Hormonal Contraceptives and Invasive Cervical Cancer
Etiology and Pathogenesis of Multiple Sclerosis
Recently added grants:
The role of linear ubiquitination in memory formation
Measuring the Multilevel Outcomes of Children's Mental Health Services Implementation
Circuit mechanisms of self-organized cognitive strategies
Mechanisms of Shear Induction of Blood-Brain Barrier Phenotypes in Human iPSC-derived Brain Endothelial Progenitors
Molecular and Cellular Control of Collective Cell Migration.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-006
Application #
6828776
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant